Burden of Illness Economic Model for Patients with Non-alcoholic Steatohepatitis (NASH) in the United States

被引：0
|
作者：
Younossi, Zobair M. [1 ,2 ]
Priyadarshini, Masoom [2 ]
Afendy, Mariam [2 ]
Nader, Fatema [3 ]
Younossi, Issah [3 ]
Racila, Andrei [2 ,3 ]
Stepanova, Maria [3 ]
机构：
[1] Inova Fairfax Hosp, Dept Med, Ctr Liver Dis, Falls Church, VA USA
[2] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[3] Ctr Outcomes Res Liver Dis, Washington, DC USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2114
引用
收藏
页码：1115A / 1116A
页数：2
相关论文
共 50 条
  • [11] The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
    Michal Witkowski
    Søren Ilsøe Moreno
    João Fernandes
    Pierre Johansen
    Margarida Augusto
    Sunita Nair
    PharmacoEconomics, 2022, 40 : 751 - 776
  • [12] Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives
    Torre, Enrico
    Di Matteo, Sergio
    Bruno, Giacomo Matteo
    Martinotti, Chiara
    Valentino, Maria Chiara
    Testino, Gianni
    Rebora, Alberto
    Bottaro, Luigi Carlo
    Colombo, Giorgio Lorenzo
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2022, 14 : 607 - 618
  • [13] Non-alcoholic steatohepatitis (NASH) in patients with chronic hepatitis
    Perez-Carreras, M
    Castellano, G
    Rivas, E
    Colina, F
    Alvarez, V
    Tomas, E
    Fuertes, A
    Solis-Herruzo, JA
    HEPATOLOGY, 2002, 36 (04) : 726A - 726A
  • [14] BURDEN OF ILLNESS AND ECONOMIC IMPACT OF NONALCOHOLIC STEATOHEPATITIS (NASH) IN THE UNITED STATES ACCORDING TO THE PRESENCE OF OBESITY
    Younossi, Zobair M.
    Paik, James M.
    Henry, Linda
    Yang, Joe
    Fernandes, Gail
    Stepanova, Maria
    Nader, Fatema
    HEPATOLOGY, 2021, 74 (06) : 1385A - 1385A
  • [15] UNDERSTANDING THE HUMANISTIC BURDEN AND PATIENT IMPACT IN NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Oliver, L.
    Tavella, F.
    Rousseau, B.
    VALUE IN HEALTH, 2019, 22 : S590 - S591
  • [16] Sarcopenia in Non-alcoholic Steatohepatitis (NASH)
    Liu C.-H.
    Habig G.
    Smaltz C.
    Halegoua-DeMarzio D.
    Current Hepatology Reports, 2021, 20 (4) : 117 - 127
  • [17] Therapies in non-alcoholic steatohepatitis (NASH)
    Oseini, Abdul M.
    Sanyal, Arun J.
    LIVER INTERNATIONAL, 2017, 37 : 97 - 103
  • [18] THE BURDEN OF NON-ALCOHOLIC STEATOHEPATITIS (NASH) IN THE EU5 COUNTRIES
    Le Pen, C.
    Fricke, F. U.
    Newsome, P.
    Schattenberg, J. M.
    Serfaty, L.
    Aghemo, A.
    Augustin, S.
    Tsochatzis, E.
    Canbay, A.
    de Ledinghen, V
    Bugianesi, E.
    Romero-Gomez, M.
    Ryder, S.
    Bantel, H.
    Boursier, J.
    Petta, S.
    Crespo, J.
    Castera, L.
    Leroy, V
    Elliott, R. A.
    Atella, V
    Mestre-Ferrandiz, J.
    Floros, L.
    Torbica, A.
    Morgan, A.
    Hartmanis, S.
    Trylesinski, A.
    Cure, S.
    Stirzaker, E.
    Vasudevan, S.
    Pezzullo, L.
    Ratziu, V
    VALUE IN HEALTH, 2019, 22 : S621 - S621
  • [19] Components of Metabolic Syndrome and the Rising Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in the United States
    Stepanova, Maria
    Afendy, Mariam
    Vernon, Gregory C.
    Nader, Fatema
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2011, 140 (05) : S988 - S988
  • [20] Economic burden of non-alcoholic steatohepatitis with significant fibrosis in Thailand
    Pochamana Phisalprapa
    Ratthanon Prasitwarachot
    Chayanis Kositamongkol
    Pranaidej Hengswat
    Weerachai Srivanichakorn
    Chaiwat Washirasaksiri
    Sombat Treeprasertsuk
    Phunchai Charatcharoenwitthaya
    Nathorn Chaiyakunapruk
    BMC Gastroenterology, 21
12345